Your browser doesn't support javascript.
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic.
Hansel, K; Zangrilli, A; Bianchi, L; Peris, K; Chiricozzi, A; Offidani, A; Diotallevi, F; Fargnoli, M C; Esposito, M; Amerio, P; Gualdi, G; Bianchi, L; Stingeni, L.
  • Hansel K; Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
  • Zangrilli A; Dermatology Unit, Policlinico Tor Vergata, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Bianchi L; Dermatology Unit, Policlinico Tor Vergata, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Peris K; Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Chiricozzi A; Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Offidani A; Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
  • Diotallevi F; Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
  • Fargnoli MC; Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Esposito M; Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Amerio P; Department of Medicine and Aging Science, Dermatologic Clinic, G. D'Annunzio University, Chieti, Italy.
  • Gualdi G; Department of Medicine and Aging Science, Dermatologic Clinic, G. D'Annunzio University, Chieti, Italy.
  • Bianchi L; Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
  • Stingeni L; Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
J Eur Acad Dermatol Venereol ; 35(3): e169-e170, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-880913
Semantic information from SemMedBD (by NLM)
1. risankizumab ASSOCIATED_WITH Psoriasis
Subject
risankizumab
Predicate
ASSOCIATED_WITH
Object
Psoriasis
2. risankizumab ASSOCIATED_WITH Psoriasis
Subject
risankizumab
Predicate
ASSOCIATED_WITH
Object
Psoriasis
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 / Antibodies, Monoclonal Type of study: Experimental Studies / Observational study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2021 Document Type: Article Affiliation country: Jdv.17003

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 / Antibodies, Monoclonal Type of study: Experimental Studies / Observational study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2021 Document Type: Article Affiliation country: Jdv.17003